Literature DB >> 9877321

Enantioselectivity of some 1-(benzofuran-2-yl)-1-(1-H-imidazol-1-yl) alkanes as inhibitors of P450Arom.

G A Khodarahmi1, H J Smith, P J Nicholls, M Ahmadi.   

Abstract

The low stereospecificity of the enantiomers of 1-[(benzofuran-2-yl)-4-chlorophenylmethyl]imidazole (6, R=H, R'=4'-Cl) and the corresponding 4-fluoro compound as inhibitors of aromatase (P450Arom) has been explored using 1-(5,7-dichlorobenzofuran-2-yl)-1-(1H-imidaz-1-yl)ethane (7, R1=R2=Cl, R=CH3), -propane (7, R1=R2=Cl, R=C2H5), and the corresponding 5,7-dibromo compounds resolved as their dibenzoyl-D (or -L) tartrates. Low enantioselectivity ratios of 4.8 (5,7-diCl) and 12.6 (5,7-diBr) were shown for the ethanes. The values for the corresponding propanes were 8.3 and 5.2, respectively, and for these compounds the stereoselectivity was reversed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9877321     DOI: 10.1111/j.2042-7158.1998.tb03352.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  2 in total

1.  Quantum mechanical/molecular mechanical and docking study of the novel analogues based on hybridization of common pharmacophores as potential anti-breast cancer agents.

Authors:  Parvin Asadi; Ghadamali Khodarahmi; Hossein Farrokhpour; Farshid Hassanzadeh; Lotfollah Saghaei
Journal:  Res Pharm Sci       Date:  2017-06

Review 2.  Benzofuran as a promising scaffold for the synthesis of antimicrobial and antibreast cancer agents: A review.

Authors:  Ghadamali Khodarahmi; Parvin Asadi; Farshid Hassanzadeh; Elham Khodarahmi
Journal:  J Res Med Sci       Date:  2015-11       Impact factor: 1.852

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.